Clonallon have been shortlisted for this year’s HealthTech Innovation Awards, taking place on Wednesday, November 23rd in the Mansion House Dublin. The category we have been shortlisted for is ‘Diagnostics for Prevention’ and submitted our application with a new to market product, A-View.
One of the drawbacks of Transoesophageal (Oesophageal) Echocardiography (TEE) or (TOE) is that virtually all of the distal ascending aorta (DAA) and aortic arch is ‘blind’ to this method as a result of the interposition of the air-filled trachea.
A-View® Endotracheal Balloon Catheter is used to overcome the limitation of the so called ‘blind spot’ of TEE and provides full visualization of the distal ascending aorta, aortic arch, and its branching vessels; allowing for real time adjustment in surgical strategy to prevent patient stroke or other brain damage.
We are incredibly proud to have been shortlisted for such a prestigious award and look forward to attending the event.
More information on A-View can be found on our website using the below link;